LabCorp to Distribute Sera's PreTRM Test, Lead $40M Series C Round | GenomeWeb

NEW YORK (GenomeWeb) – Sera Prognostics said today it has tapped Laboratory Corporation of America to be the exclusive US distributor of Sera's PreTRM test for preterm birth.

Sera noted that LabCorp's existing non-invasive prenatal testing, women's healthcare, and reproductive genetics businesses make it well positioned to drive commercialization of the test.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.